Population
Patients with hypertension and angina pectoris
Design
Review
Authors
Loading...
May support renewed interest in T-channel antagonists for hypertension and angina; leaves open need for modern randomized validation.
Mibefradil is a novel T-channel selective calcium antagonist that provides effective treatment for hypertension and angina pectoris with a favorable safety profile.
William H. Frishman (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: